Next 10 |
home / stock / gikly / gikly news
2024-03-05 10:19:08 ET Summary Grifols faces new accusations from the hedge fund Gotham City. Gotham City questions loans and outgoing flows recorded in Grifols' financial report, as well as the role of Scranton Enterprises. Grifols disclosed a lack of FCF generation in 2024. ...
2024-02-05 14:20:46 ET More on Grifols Grifols: Wait And See For Now Grifols: I've Read The Short-Seller Report, And I Mostly Disagree Grifols Is Building Momentum Grifols’ banking exposure under ECB scrutiny: Reuters ELAB, KIND and RLX among p...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Grifols To Contact Him Directly To Discuss Their Options If you suffered significant losses in Grifols stock or options and would like to discuss your legal rights, call Faruqi & Faruq...
2024-01-17 14:56:12 ET More on Grifols S.A. Grifols: Wait And See For Now Grifols: I've Read The Short-Seller Report, And I Mostly Disagree Grifols Is Building Momentum ELAB, KIND and RLX among pre-market losers Haier Group still looking to buy Shangh...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Grifols To Contact Him Directly To Discuss Their Options If you suffered significant losses in Grifols stock or options and would like to discuss your legal rights, call Faruqi & Faruq...
2024-01-10 13:15:00 ET Summary Gotham City's recent allegations against Grifols have caused GFRS stock to significantly decline. Our team at Mare will remain waiting for clarifications. We expect the company's stock to be under pressure in the short term and probably not investabl...
2024-01-09 06:46:54 ET More on Grifols S.A. Grifols Is Building Momentum Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript Grifols gains on plans to sell 20% of Shanghai RAAS stake to Haier Grifols said to be in talks for a partial sale of Shanghai RAAS ...
2023-12-22 17:56:28 ET Summary The biotech bear market has presented investment opportunities for investors to take meaningful stakes in public companies at venture valuations. AI drug discovery has faced setbacks in the past 18 months, but Gain Therapeutics' has found success usi...
2023-12-08 17:34:26 ET Summary Argenx's failure removes competitive pressure on Grifols' immunoglobulin franchise. Grifols is in advanced negotiations to sell Shanghai RAAS, which would eliminate short-term debt concerns. Grifols' Q3 results showed increased sales, improved EB...
2023-11-29 08:21:29 ET More on Grifols Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript Grifols: Cheap For A Reason Historical earnings data for Grifols, S.A. Financial information for Grifols, S.A. Historical earnings data for Grifols, S.A. ...
News, Short Squeeze, Breakout and More Instantly...
Grifols SA Barcelona ADR Company Name:
GIKLY Stock Symbol:
OTCMKTS Market:
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Grifols To Contact Him Directly To Discuss Their Options If you suffered significant losses in Grifols stock or options and would like to discuss your legal rights, call Faruqi & Faruq...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Grifols To Contact Him Directly To Discuss Their Options If you suffered significant losses in Grifols stock or options and would like to discuss your legal rights, call Faruqi & Faruq...
Grifols reaches milestone with 300th U.S. plasma donor center, continuing to increase supply of urgently needed plasma - The new Biomat USA plasma donor center, located at UMass Chan Medical School campus in Worcester, Mass., is Grifols' first donor center in the state and secon...